Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Quidel Corp (NASDAQ:QDEL)

37.71
Delayed Data
As of 4:00pm ET
 -0.02 / -0.05%
Today’s Change
18.25
Today|||52-Week Range
38.92
+76.05%
Year-to-Date
Abbott CEO Discusses Additional Divestiture In Connection with Alere Buy
Jul 20 / TheStreet.com - Paid Partner Content
Quidel (QDEL) Worth a Look: Stock Jumps 25.4% in Session
Jul 18 / Zacks.com - Paid Partner Content
Alere , St. Jude Deals In Focus as Abbott Releases Second Quarter Earnings
Jul 19 / TheStreet.com - Paid Partner Content
Action Was Under the Surface in Monday's Market
Jul 17 / TheStreet.com - Paid Partner Content
Quidel Diversifies With Alere's Triage Assets
Jul 18 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close37.73
Today’s open38.24
Day’s range37.46 - 38.45
Volume411,488
Average volume (3 months)245,760
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-133.33%
Earnings growth (this year)+205.24%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-2.31%
P/E ratio342.8
Price/Sales3.66
Price/Book6.19

Competitors

 Today’s
change
Today’s
% change
--Quidel Corp-0.33-1.03%
IMMUImmunomedics Inc+0.04+0.46%
MYGNMyriad Genetics Inc-0.16-0.66%
ALRPRBAlere Inc-0.81-0.20%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$191.6M
Annual profit (last year)-$13.8M
Net profit margin-7.21%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Douglas C. Bryant
Senior Vice President-
Global Commercial Operations
Edward Kieth Russell
Corporate headquarters
San Diego, California

Forecasts